Skip to content

Universal Health Realty Income Trust stock

UHTNYSE

Real EstateISIN US91359E1055

$38.68▼ $0.35 (−0.9%)Closing price of 12 Nov 2026

61Score 61 out of 100, Neutral

Turn on early warning

Price and trend

62 / 100

Price history

−1.9% in one year

The chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.

Long-term trend

Below the 200-day line: the price is 5.8% below it.

Trend change

Since September 2026 the 50-day line has been below the 200-day line; the trend has turned down.

Momentum

Normal: the price is neither overheated nor sold off (RSI 58).

Distance to the high

The price is 16% below its 52-week high. Largest decline in 20 years: 75% (February 2020 to April 2024).

Chart figures for advanced users
SMA 50$38.60
Average price of the last 50 trading days, shows the short-term trend.
SMA 200$41.07
Average price of the last 200 trading days, shows the long-term trend.
RSI (14)58
Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
MACDabove the signal line
Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
Support$36.43
The lowest closing price of the last twelve months.
Resistance$45.82
The highest closing price of the last twelve months.
Market cap
$542.5M
Div. yield
7.66%
12 months
26.9
says little for REITs
Fair value
$61.74

Snapshot

Computed from the data by fixed rules, no AI

  • Universal Health Realty Income Trust belongs to the REIT (Healthcare Facilities) industry (United States) and, with a market value of $537.64M, is number 16 of 18 companies in its industry on MEQIRI.
  • In fiscal 2025 it reported revenue of $99.19M (up 0.2% year on year) and earnings of $17.61M (down 8.4%).
  • MEQIRI Score 61 out of 100 (Neutral): rank 79 of 327 in Real Estate, median 55.
Show more
  • The P/E is 26.6 (REIT (Healthcare Facilities) median 14.5, own median of recent years 33).
  • For real estate investment trusts (REITs) what counts is funds from operations (FFO and AFFO). The P/E and the payout ratio of earnings say little here, because depreciation on properties depresses earnings.
  • Our model puts fair value at $61.74, with the price 37% below it.

In plain words

The numbers on this page in plain words, written by an AI

Strengths

  • Reliable dividendNo dividend cut for over 39 years.Capital allocation 55
  • Earnings turn into cashFree cash flow 243% of earnings over the last 12 months.Fundamentals 86
  • Below fair valuePrice 37% below the fair value of $61.74.Valuation 66

Weaknesses

  • High debtDebt 2.75 times equity (latest quarter), REIT (Healthcare Facilities) median 0.84.Stability 52
  • Interest barely coveredOperating profit covers interest only 1.8 times.Stability 52
61/ 100
MEQIRI Score
Neutral

Its standout strengths are fundamentals and profitability, while growth holds the score back.

Daily figure as of 12 Nov 2026

How the score is calculated

Score overview

Fundamentals are strong, with stable profits and strong cash generation.

Profit consistency100% of years
Cash conversion (free cash flow to earnings, 12 months)243%
ROIC (12 months)10.3%
Positive free cash flow90% of years
How this category is measured

Score history

The full history of up to 20 years comes with MEQIRI Pro.

See plans

Crash risk low

How well MEQIRI warns

One of the 30% with the lowest crash risk among smaller stocks.

From 2016 to 2025, 14 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.

What lowers it

  • solid fundamentals
  • calm price action

Valuation

Valuation signal

Significantly undervalued
Price
$39.03
Fair value
$61.74
Gap to fair value
−37%

Closing price of 11 Nov 2026, used by the daily score.

In our model the price counts as cheap below $51.45 and expensive above $77.18 (uncertainty low, based on the price swings of the past year).

The two parts of the fair value come to $65.30 (cash-flow model) and $58.18 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is below both.

Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $56.30, at 7.8% it would be $69.90.

Valuation metrics

3.75
14.5
Fair value (model)
$61.74
Industry part $58.18 (FFO × 16.9)

Half from the cash-flow model, half from FFO per share times the median price to FFO of the REIT industry (16.9). For REITs, depreciation on buildings depresses earnings, so FFO counts instead of earnings. The cash-flow model uses AFFO: operating cash flow less maintenance, estimated at 4% of revenue. New construction and acquisitions do not count as running costs there.

Calculate with your own assumptions

Company performance

This shows several years of history with an automatic assessment.

Revenue

20 years

In the twelve months to 30 Sep 2026, revenue was roughly flat on the twelve months before. Revenue has grown solidly since 2006, at about 6% per year.

Margins

20 years
  • Gross margin
  • Operating margin
  • Net margin

In fiscal 2025: gross 94%, operating 35%, net 18%.

Debt & balance sheet

latest quarter
2.75
1.8x
15.19
Cash & equivalents
$6.82M

Debt is elevated. Keep an eye on the interest burden and refinancing.

Earnings

Next earnings
2 Mar 2027in 110 days
Last reported
27 Oct 2026EPS reported $0.35

Analyst estimates

Earnings estimates have barely changed since 15 Oct 2026.

Fiscal 20261 analyst
Earnings per share
$1.730.0%
Revenue
$100.4M+0.9%
Fiscal 20271 analyst
Earnings per share
$1.820.0%
Revenue
$106.6M+1.8%

MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.

Insiders

Open-market purchases and sales by executives, board members and major holders

All insider purchases

No open-market purchases or sales in the last 6 months.

Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.

What happened at Universal Health Realty Income Trust

The key events of the last six months from our own data. A click takes you to the matching card.

Sector comparison

327 rated companies in Real Estate

Rank 79 of 327
79/ 327
This company
61
Sector median
55

Categories against the sector median

ProfitabilityMedian of 327 companies70 (median 57)13 above the median
GrowthMedian of 327 companies42 (median 55)13 below the median
FundamentalsMedian of 327 companies86 (median 62)24 above the median
ValuationMedian of 315 companies with a value66 (median 68)2 below the median
StabilityMedian of 327 companies52 (median 56)4 below the median
Capital allocationMedian of 327 companies55 (median 32)23 above the median
Technical analysisMedian of 327 companies62 (median 59)3 above the median
MomentumMedian of 327 companies54 (median 51)3 above the median

The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.

Competitors in REIT (Healthcare Facilities)

The next larger and next smaller companies by market value

All 18 REIT (Healthcare Facilities) stocks

ETFs that hold Universal Health Realty Income Trust

Held by 7 ETFs on Xetra. Shown per index: the ETF with the largest weight.

Show 2 more

Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).

Data status and sources

Score
Daily value of 12 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Neutral, published since 7 Nov 2026 (in the score history since 17 Jan 2025)
  • Valuation signal Undervalued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy